491 related articles for article (PubMed ID: 12377838)
1. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
Hadjiliadis D; Davis RD; Palmer SM
Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
[TBL] [Abstract][Full Text] [Related]
2. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients.
Finlen Copeland CA; Snyder LD; Zaas DW; Turbyfill WJ; Davis WA; Palmer SM
Am J Respir Crit Care Med; 2010 Sep; 182(6):784-9. PubMed ID: 20508211
[TBL] [Abstract][Full Text] [Related]
3. Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation.
Hennessy SA; Hranjec T; Swenson BR; Kozower BD; Jones DR; Ailawadi G; Kron IL; Lau CL
Ann Thorac Surg; 2010 May; 89(5):1555-62. PubMed ID: 20417777
[TBL] [Abstract][Full Text] [Related]
4. Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients.
Hall DJ; Baz M; Daniels MJ; Staples ED; Klodell CT; Moldawer LL; Beaver TM
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):603-7. PubMed ID: 22815323
[TBL] [Abstract][Full Text] [Related]
5. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
[TBL] [Abstract][Full Text] [Related]
7. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
[TBL] [Abstract][Full Text] [Related]
8. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
[TBL] [Abstract][Full Text] [Related]
9. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
[TBL] [Abstract][Full Text] [Related]
11. Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS).
Fisher AJ; Wardle J; Dark JH; Corris PA
J Heart Lung Transplant; 2002 Nov; 21(11):1206-12. PubMed ID: 12431494
[TBL] [Abstract][Full Text] [Related]
12. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
Jaksch P; Taghavi S; Klepetko W; Salama M
J Thorac Cardiovasc Surg; 2014 Jul; 148(1):273-81. PubMed ID: 24685381
[TBL] [Abstract][Full Text] [Related]
13. Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation.
Moore CA; Pilewski JM; Venkataramanan R; Robinson KM; Morrell MR; Wisniewski SR; Zeevi A; McDyer JF; Ensor CR
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273385
[TBL] [Abstract][Full Text] [Related]
14. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric Predictors of Long-term Transplant-Related Outcomes in Lung Transplant Recipients.
Rosenberger EM; DiMartini AF; DeVito Dabbs AJ; Bermudez CA; Pilewski JM; Toyoda Y; Dew MA
Transplantation; 2016 Jan; 100(1):239-47. PubMed ID: 26177087
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.
Jain R; Hachem RR; Morrell MR; Trulock EP; Chakinala MM; Yusen RD; Huang HJ; Mohanakumar T; Patterson GA; Walter MJ
J Heart Lung Transplant; 2010 May; 29(5):531-7. PubMed ID: 20133163
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.
Chalermskulrat W; Neuringer IP; Schmitz JL; Catellier DJ; Gurka MJ; Randell SH; Aris RM
Chest; 2003 Jun; 123(6):1825-31. PubMed ID: 12796156
[TBL] [Abstract][Full Text] [Related]
18. Double lung, unlike single lung transplantation might provide a protective effect on mortality and bronchiolitis obliterans syndrome.
Fakhro M; Broberg E; Algotsson L; Hansson L; Koul B; Gustafsson R; Wierup P; Ingemansson R; Lindstedt S
J Cardiothorac Surg; 2017 Nov; 12(1):100. PubMed ID: 29178919
[TBL] [Abstract][Full Text] [Related]
19. Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.
Lama VN; Murray S; Lonigro RJ; Toews GB; Chang A; Lau C; Flint A; Chan KM; Martinez FJ
Am J Respir Crit Care Med; 2007 Jun; 175(11):1192-8. PubMed ID: 17347496
[TBL] [Abstract][Full Text] [Related]
20. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]